{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:31:24Z","timestamp":1784212284494,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jpsychires.2024.09.048","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:59:29Z","timestamp":1727719169000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Efficacy of pharmacological treatment in OCD comorbid with tic disorder: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8331-4544","authenticated-orcid":false,"given":"Isabelle","family":"Jalenques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Asatryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urbain","family":"Tauveron-Jalenques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8998-1559","authenticated-orcid":false,"given":"Fabien","family":"Rondepierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2024.09.048_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR","year":"2022"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1017\/S109285292100081X","article-title":"Assessing response, remission, and treatment resistance in patients with obsessive-compulsive disorder with and without tic disorders: results from a multicenter study","volume":"27","author":"Benatti","year":"2022","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-1781(00)00203-1","article-title":"Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial","volume":"96","author":"Bogetto","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib4","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","article-title":"Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials","volume":"297","author":"Bridge","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib5","article-title":"Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study","volume":"5","author":"Carey","year":"2005","journal-title":"BMC Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib6","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jaac.2014.09.014","article-title":"Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II","volume":"53","author":"Conelea","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/JCP.0000000000000748","article-title":"Aripiprazole monotherapy was effective in treating obsessive-compulsive disorder in a preschool boy","volume":"37","author":"Coskun","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib8","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jpsychires.2013.07.006","article-title":"Can early improvement be an indicator of treatment response in obsessive-compulsive disorder? Implications for early-treatment decision-making","volume":"47","author":"da Concei\u00e7\u00e3o Costa","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib9","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.pnpbp.2007.07.008","article-title":"Successful augmentation with aripiprazole in clomipramine-refractory obsessive\u2013compulsive disorder","volume":"31","author":"Da Rocha","year":"2007","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1017\/S1092852900023014","article-title":"Early onset obsessive-compulsive disorder with and without tics","volume":"14","author":"de Mathis","year":"2009","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib11","doi-asserted-by":"crossref","DOI":"10.47626\/1516-4446-2022-2891","article-title":"Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment","author":"De Oliveira","year":"2023","journal-title":"Brazilian Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2174\/1570159X16666180813155017","article-title":"Psychopharmacological treatment of obsessive-compulsive disorder (OCD)","volume":"17","author":"Del Casale","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1192\/bjp.157.5.762","article-title":"Fluvoxamine\/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder","volume":"157","author":"Delgado","year":"1990","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyv047","article-title":"Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials","volume":"18","author":"Dold","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2352-4642(22)00316-9","article-title":"Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis","volume":"7","author":"Farhat","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/YIC.0000000000000314","article-title":"Clinical advances in obsessive-compulsive disorder: a position statement by the international College of obsessive-compulsive spectrum disorders","volume":"35","author":"Fineberg","year":"2020","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/cap.1999.9.115","article-title":"Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder","volume":"9","author":"Fitzgerald","year":"1999","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/JCP.0000000000001716","article-title":"Clinical recommendations for augmentation agents in obsessive-compulsive disorder partially responsive to serotonin reuptake inhibitors","volume":"43","author":"Gautam","year":"2023","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib21","first-page":"353","article-title":"Obsessive-compulsive and spectrum disorders in children and adolescents","volume":"29","author":"Geller","year":"2006","journal-title":"Psychiatr. Clin."},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2024.09.048_bib22","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/104454603322126313","article-title":"Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?","volume":"13","author":"Geller","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/10870547231217091","article-title":"A family genetic study of obsessive compulsive disorder in youth","volume":"28","author":"Geller","year":"2024","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hup.470080505","article-title":"Fluvoxamine and sulpiride in comorbid obsessive-compulsive disorder and Gilles de la Tourette Syndrome","volume":"8","author":"George","year":"1993","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00416","article-title":"Aripiprazole improves associated comorbid conditions in addition to tics in adult patients with Gilles de la Tourette Syndrome","volume":"10","author":"Gerasch","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00004583-199606000-00008","article-title":"Combined pharmacotherapy for TS and OCD","volume":"35","author":"Hawkridge","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpsychires.2006.05.007","article-title":"Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder","volume":"41","author":"Husted","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1017\/S1092852900013791","article-title":"Obsessive-compulsive disorder with and without tic disorder: a comparative study from India","volume":"13","author":"Jaisoorya","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib31","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1017\/S1461145709990393","article-title":"Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder","volume":"12","author":"Lai","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00004583-199509000-00011","article-title":"Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report","volume":"34","author":"Lombroso","year":"1995","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biopsych.2006.09.035","article-title":"Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder","volume":"61","author":"March","year":"2007","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jpsychires.2013.04.003","article-title":"Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study","volume":"47","author":"Masi","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib35","first-page":"150","article-title":"Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania","volume":"40","author":"Matur","year":"2003","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","article-title":"A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder","volume":"57","author":"McDougle","year":"2000","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00004714-199310000-00008","article-title":"The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder","volume":"13","author":"McDougle","year":"1993","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archpsyc.1994.03950040046006","article-title":"Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics","volume":"51","author":"McDougle","year":"1994","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/da.22389","article-title":"A META-ANALYSIS of COGNITIVE BEHAVIOR THERAPY and MEDICATION for CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS of TREATMENT EFFICACY, RESPONSE, and REMISSION","volume":"32","author":"McGuire","year":"2015","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1440-1819.2003.01139.x","article-title":"Citalopram treatment of children and adolescents with obsessive-compulsive disorder: a preliminary report","volume":"57","author":"Mukaddes","year":"2003","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat. Med."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib42","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.pnpbp.2005.11.028","article-title":"Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines","volume":"30","author":"Pallanti","year":"2006","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib43","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ajmg.b.32436","article-title":"Understanding the covariation of tics, attention\u2010deficit\/hyperactivity, and obsessive\u2010compulsive symptoms: a population\u2010based adult twin study","volume":"171","author":"Pinto","year":"2016","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatric Genetics"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-3223(90)90023-U","article-title":"Clomipramine efficacy for tics, obsessions, and compulsions in Tourette's syndrome and obsessive-compulsive disorder: a case study","volume":"27","author":"Ratzoni","year":"1990","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00787-021-01899-z","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders\u2014version 2.0. Part III: pharmacological treatment","volume":"31","author":"Roessner","year":"2022","journal-title":"Eur. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib46","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/00004583-199909000-00024","article-title":"Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder","volume":"38","author":"Rosenberg","year":"1999","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib47","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.4088\/JCP.v66n1204","article-title":"Clinical predictors of drug nonresponse in obsessive-compulsive disorder","volume":"66","author":"Shetti","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib48","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euroneuro.2006.07.002","article-title":"Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials","volume":"17","author":"Skapinakis","year":"2007","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib50","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jad.2017.04.068","article-title":"Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: a meta-analysis","volume":"218","author":"Sugarman","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib52","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/15622975.2022.2082525","article-title":"Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a network meta-analysis of randomised controlled trials","volume":"24","author":"Suhas","year":"2023","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-014-0317-5","article-title":"Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"14","author":"Veale","year":"2014","journal-title":"BMC Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib54","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/JCP.0b013e31817d86cc","article-title":"Aripiprazole in a case presenting with tourette syndrome and obsessive-compulsive disorder","volume":"28","author":"Winter","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.048_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012959","article-title":"Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both?","volume":"5","author":"Worbe","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pnpbp.2018.12.009","article-title":"Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: a network meta-analysis","volume":"90","author":"Zhou","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.09.048_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jpsychires.2019.01.014","article-title":"Comparative efficacy and tolerability of antipsychotics as augmentations in adults with treatment-resistant obsessive-compulsive disorder: a network meta-analysis","volume":"111","author":"Zhou","year":"2019","journal-title":"J. Psychiatr. Res."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624005703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624005703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T18:39:43Z","timestamp":1736275183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395624005703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"alternative-id":["S0022395624005703"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.09.048","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of pharmacological treatment in OCD comorbid with tic disorder: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.09.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}